Connect with us
Human challenge trials involve deliberately exposing healthy volunteers to pathogens to speed up the development of vaccines and treatments. Volunteers are often motivated by a commitment...
Researchers have developed a nanoparticle-based vaccine that trains the immune system to recognize regions shared by eight different coronaviruses, potentially offering protection against future outbreaks. This...
Study reveals how SARS-CoV-2 utilizes lysosomes for replication, potentially paving the way for new antiviral therapies. Findings highlight the importance of understanding viral replication mechanisms beyond...
Stanford research links indoor humidity levels to seasonality of respiratory illnesses like COVID-19 and flu. Higher humidity levels enhance the formation of disinfectant compounds in airborne...
Filippa Lentzos launches report at UN Headquarters, emphasizing the need for global governance in high-risk pathogen research post-COVID-19. Report underscores critical gap in global occupational health...
Iron dysregulation due to SARS-CoV-2 infection could be a key trigger for long COVID, with ongoing inflammation and disrupted iron levels seen early post-infection. Early detection...
Study in Nature Communications finds persistent brain injury markers in COVID-19 patients’ blood months post-infection, particularly evident in those with neurological complications during acute illness and...
Interrupting immune-suppressing treatment for two weeks post-COVID booster doubled antibody response for six months in inflammatory condition patients. Full trial findings support enhanced protection without increased...
A person’s vulnerability to different SARS-CoV-2 variants is influenced by their initial exposure, shaping their immune response and affecting vaccine effectiveness. The study highlights the need...
Studies of a ‘future-proof� vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. The studies...
